13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Instead the range of laboratory reference values are shifted downward to reflect those in human subjects as they advance in age
After completing the first two steps, you will have access to all of the DEX Z-Code Identifiers assigned to Quest
Over the last 3 months, there has been a sudden increase in the size and extent of the lesion for which she reached out
Participants in the trial extension received retatrutide at a maximum tolerated dose of 9 mg or 12 mg
Peptides that sit in hot warehouses, ship without ice packs, or arrive in non-insulated packaging can degrade significantly before you ever open the vial